🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Harper Hubbeling

Hospital of the University of Pennsylvania

ORCID: 0000-0003-4812-5235

Also affiliated with University of Pennsylvania

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma”.

Conventional and novel [18F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01540-x

N/A

0.557DataRank · unranked

40 citations

Jessica Flynn, Sean M. Devlin, Audrey Mauguen, Teng Fei, Shang Zeng +23 more

Resistance to lorlatinib in ROS1 fusion-positive non-small cell lung cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9611

N/A

0.457DataRank · unranked

20 citations

Ted W. Johnson, Jochen K. Lennerz, Charlotte Lee, Harper Hubbeling, Beow Y. Yeap +4 more

Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib

Lung Cancer(2023)10.1016/j.lungcan.2023.02.005

N/A

0.330DataRank · unranked

8 citations

Jordan Eichholz, Emily S. Lebow, Jessica Flynn, Zhigang Zhang, Henry Walch +14 more

Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019

JAMA Health Forum(2022)10.1001/jamahealthforum.2022.1815

N/A

0.241DataRank · unranked

4 citations

Harper Hubbeling, Fumiko Chino, Carla Hajj, Joachim Yahalom, Brandon S. Imber +1 more

413 | PROGRESSION PATTERNS BY POSITRON EMISSION TOMOGRAPHY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER CAR T CELL THERAPY: POTENTIAL ROLE FOR RADIOTHERAPY?

Hematological Oncology(2025)10.1002/hon.70094_413

N/A

0DataRank · unranked

0 citations

Harper Hubbeling, B. Fregonese, G. Cederquist, Nikhil P. Mankuzhy, Roshal R. Patel +8 more